Effect of Perioperative Glucose-Insulin-Potassium Therapy in Patients Undergoing On-Pump Cardiac Surgery: A Meta-Analysis.

CONCLUSIONS: In patients undergoing on-pump cardiac surgery, GIK infusion has a beneficial role in mortality during hospital stay and demonstrates superior efficacy versus standard care for reduction in postoperative MI, AF, ICU length of stay as well as inotropic agent requirements.
PMID: 32118546 [PubMed - as supplied by publisher]

Source: The Heart Surgery Forum - February 24, 2020 Category: Cardiovascular & Thoracic Surgery Authors: Li Q, Yang J, Zhang J, Yang C, Fan Z, Yang Y, Zheng T, Yang J Tags: Heart Surg Forum Source Type: research